A germination bioassay as a toxicologial screening system for studying the effects of potential prodrugs of naproxen
By Gonzalex-de la Parra, M. - Ramos-Mundo, C. - Jimenez-Estrada, M. - Ponce-de Leon, C. - Castillo, R. - Tejeda, V. - Cuevas, K.G. - Enriquez, R.G.
| Record number: | 2928428 |
|---|---|
| Category: | nonsteroidal anti-inflammatory agents - seed germination - Raphanus sativus - screening - enantiomers - esters - experimental design - structure-activity relationships - molecular conformation - pharmacology - animal use alternatives |
A germination bioassay with radish (Raphanus sativus L.) seeds was developed as a toxicological screening system for assessing the effects of new potential prodrugs of naproxen as an alternative to animals and animal cell toxicity screens. Both enantiomers of naproxen (6-methoxy-alpha-methyl-2-naphthaleneacetic acid) and naproxol (6-methoxy-beta-2-naphthaleneethanol), and their racemic mixtures, inhibited the radicle growth of R. sativus at a concentration of 1mM, while only (R)-(+)-naproxol and racemic naproxol inhibited the hypocotyl growth of R. sativus at the same concentration. Four novel combinatorial esters, naproxen naproxyl esters (6-methoxy-beta-methyl-2-naphthaleneethyl 6-methoxy-alpha-methyl-2-naphthaleneacetate), resulting from the combinatorial chemistry of the esterification reaction between naproxen and naproxol, were synthesised and then tested in the germination bioassay, at a concentration of 0.5mM. It was found that they did not inhibit either the radicle or the hypocotyl growth of R. sativus.
Issued: Sept/Oct 1998
Journal Title: Alternatives to laboratory animals
ISSN: 0261-1929
Volume issue: 26 v. 5 no.
Pages: 635 - 647
AGRICOLA identifier: IND21989821
Thanks for your feedback! Please note that we cannot reply to you unless you send us an email.
What are you looking for?
We value your feedback so we can improve the information on the page. Please add your email address if you would like a reply. Thank you in advance for your help.!
Please contact us by email if you have any questions.